CEACAM5 and rectal cancer: We examined several well-known clinical predictors of rectal cancer treatment response, including CEA, Hb, white blood cell (WBC) count, neutrophil/lymphocyte ratio (N/L ratio), and platelet/lymphocyte ratio (P/L ratio).